Ciprofloxacin for infection prevention in patients with acute leukemia
- PMID: 3325929
- DOI: 10.1007/BF02075259
Ciprofloxacin for infection prevention in patients with acute leukemia
Abstract
Ciprofloxacin, a new quinolone derivative, was given prophylactically (500 mg twice daily) to 15 patients with acute leukemia during remission induction treatment. The effect on the microbial flora of the alimentary tract was evaluated. A rapid elimination of Enterobacteriaceae was observed. Bacteriodes and Clostridium species were not affected. Few ciprofloxacin resistant strains were isolated but did not lead to colonization. In a randomized study 56 patients with acute leukemia received either ciprofloxacin or trimethoprim-sulfamethoxazole plus colistin for prevention of infections. Six major infections occurred in 28 patients receiving ciprofloxacin, and 11 major infections in 28 patients receiving trimethoprim-sulfamethoxazole plus colistin. No infections caused by Gram-negative bacilli were seen in the ciprofloxacin group compared to 17 in the other group (p less than 0.02). Ciprofloxacin prevented colonization with resistant Gram-negative bacilli while 12 resistant colonizing strains were isolated from 10 patients receiving trimethoprim-sulfamethoxazole (p less than 0.01). Ciprofloxacin was better tolerated than trimethoprim-sulfamethoxazole + colistin; fewer side effects occurred.
Similar articles
-
Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.Ann Intern Med. 1987 Jan;106(1):7-11. doi: 10.7326/0003-4819-106-1-7. Ann Intern Med. 1987. PMID: 3466563 Clinical Trial.
-
Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria.Infection. 1983 May-Jun;11(3):167-9. doi: 10.1007/BF01641298. Infection. 1983. PMID: 6604030
-
Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia.Lancet. 1982 Jan 2;1(8262):5-6. doi: 10.1016/s0140-6736(82)92553-3. Lancet. 1982. PMID: 6119443 Clinical Trial.
-
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.Am J Med. 1984 Apr;76(4):645-51. doi: 10.1016/0002-9343(84)90289-4. Am J Med. 1984. PMID: 6369979 Review.
-
Prevention of infection in acute leukemia.Haematol Blood Transfus. 1990;33:525-30. doi: 10.1007/978-3-642-74643-7_94. Haematol Blood Transfus. 1990. PMID: 2108911 Review.
Cited by
-
Host impairments in patients with neoplastic diseases.Cancer Treat Res. 2014;161:1-41. doi: 10.1007/978-3-319-04220-6_1. Cancer Treat Res. 2014. PMID: 24706220 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical